INR 1479.15
(0.98%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.23 Billion INR | 10.99% |
2022 | 2.91 Billion INR | -6.1% |
2021 | 3.1 Billion INR | 8.78% |
2020 | 2.85 Billion INR | 28.41% |
2019 | 2.22 Billion INR | 26.59% |
2018 | 1.75 Billion INR | 9.3% |
2017 | 1.6 Billion INR | 60.21% |
2016 | 1 Billion INR | -1.1% |
2015 | 1.01 Billion INR | -11.3% |
2014 | 1.14 Billion INR | 13.01% |
2013 | 1.01 Billion INR | 41.66% |
2012 | 713.36 Million INR | 3.38% |
2011 | 690.04 Million INR | -13.63% |
2010 | 798.95 Million INR | 13.21% |
2009 | 705.72 Million INR | 19.55% |
2008 | 590.3 Million INR | 19.39% |
2007 | 494.43 Million INR | 33.73% |
2006 | 369.72 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -4.59 Billion INR | -242.03% |
2024 Q2 | 3.2 Billion INR | 169.78% |
2023 Q2 | 3.36 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 3.23 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 FY | 3.23 Billion INR | 10.99% |
2022 Q1 | - INR | -100.0% |
2022 Q4 | 2.91 Billion INR | 0.0% |
2022 FY | 2.91 Billion INR | -6.1% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 3.57 Billion INR | 0.0% |
2021 Q2 | 3.94 Billion INR | 0.0% |
2021 Q4 | 3.1 Billion INR | 0.0% |
2021 FY | 3.1 Billion INR | 8.78% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 2.85 Billion INR | 28.41% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 2.85 Billion INR | 0.0% |
2020 Q2 | 2.39 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 1.73 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 2.22 Billion INR | 26.59% |
2019 Q4 | 2.22 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 1.75 Billion INR | 9.3% |
2018 Q4 | 1.75 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 1.75 Billion INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 1.38 Billion INR | 0.0% |
2017 FY | 1.6 Billion INR | 60.21% |
2017 Q4 | 1.6 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2016 FY | 1 Billion INR | -1.1% |
2016 Q4 | 1 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 1.23 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 Q4 | 1.01 Billion INR | 0.0% |
2015 FY | 1.01 Billion INR | -11.3% |
2015 Q2 | 1.26 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q4 | 1.14 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 1.14 Billion INR | 13.01% |
2014 Q2 | 1.03 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2013 Q2 | 822.69 Million INR | 0.0% |
2013 Q4 | 1.01 Billion INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 FY | 1.01 Billion INR | 41.66% |
2012 Q3 | - INR | -100.0% |
2012 Q2 | 1.46 Billion INR | 0.0% |
2012 Q4 | 713.36 Million INR | 0.0% |
2012 FY | 713.36 Million INR | 3.38% |
2011 FY | 690.04 Million INR | -13.63% |
2010 FY | 798.95 Million INR | 13.21% |
2009 FY | 705.72 Million INR | 19.55% |
2008 FY | 590.3 Million INR | 19.39% |
2007 FY | 494.43 Million INR | 33.73% |
2006 FY | 369.72 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Poly Medicure Limited | 3.85 Billion INR | 16.165% |
Tarsons Products Limited | 3.59 Billion INR | 10.03% |